borderline significantp = 0.054
The protective effect was stronger in non‐diabetic patients (47.5% relative risk reduction) than in diabetic patients (24.4% relative risk reduction), with a borderline significant interaction ( p = 0.054). 3.5 Multiple Testing Corrections and Sensitivity Analyses Multiple testing corrections and sensitivity analyses are presented in Table 5 and Figure S2 .